Company
Nexstim
- Biotech
- Founded:
- 2000
- Location:
- Helsinki, Finland
Description
Nexstim develops a navigated transcranial magnetic stimulation system that uses sophisticated 3D navigation to provide accurate, personalized targeting of TMS for diagnostics and therapies in neurological applications.
Nexstim is located in the Helsinki ecosystem.
Related
UniogenUniogen provides biotech CDMO services, develops custom assays and laboratory instruments, and creates technologies—such as glycovariant…
- AplagonAplagon develops a therapeutic called APAC, a vascular-injury targeting molecule that combines antiplatelet, anticoagulant, and…
AidianAidian develops, manufactures, and distributes CE‑marked in vitro diagnostic tests and point‑of‑care products for clinical diagnostics and…
BiohitBiohit develops diagnostic products and services for medical research and early detection, producing assays, clinical study protocols and…
PhotocurePhotocure delivers precision diagnostics for bladder cancer, offering products and solutions that provide physicians with timely…
Herantis PharmaHerantis Pharma develops disease-modifying therapies designed to stop or reverse progression of neurodegenerative diseases, applying drug…
Agomab TherapeuticsAgomab Therapeutics develops disease-modifying therapies for fibro-inflammatory conditions through TGFβ/ALK5 (TGFβR1) pathway targeting,…
Oy Medix BiochemicaOy Medix Biochemica supplies diagnostic raw materials, including monoclonal and polyclonal antibodies, native and recombinant antigens,…
Newronika SPANewronika SPA builds an adaptive deep brain stimulation system that senses neural signals and adjusts therapy in real time; used by…